Vasculogenic mimicry (VM) formation by cancer cells is known to play a crucial role in tumor
progression, but its detailed mechanism is unclear. In the present study, we focused on …

Vasculogenic mimicry (VM) is a non-classical mechanism recently described in many
tumors, whereby cancer cells, rather than endothelial cells, form blood vessels. Transgelin is …

Vasculogenic mimicry (VM) is the formation of a blood supply system that confers aggressive
and metastatic properties to tumors and correlates with a poor prognosis in cancer patients …

Vasculogenic mimicry (VM) is a brand‐new tumour vascular paradigm independent of
angiogenesis that describes the specific capacity of aggressive cancer cells to form vessel …

Vasculogenic mimicry (VM) refers to the fluid-conducting channels formed by aggressive
tumor cells rather than endothelial cells (EC) with elevated expression of genes associated …

Targeting the tumor vasculature is an attractive strategy for cancer treatment. However, the
tumor vasculature is heterogeneous, and the mechanisms involved in the …

Vasculogenic mimicry (VM) describes the process utilized by highly aggressive cancer cells
to generate vascular-like structures without the presence of endothelial cells. VM has been …

Distinct from classical tumor angiogenesis, vasculogenic mimicry (VM) provides a blood
supply for tumor cells independent of endothelial cells. VM has two distinct types, namely …

Vasculogenic mimicry (VM), the formation of vessel-like structures by highly invasive tumor
cells, has been considered one of several mechanisms responsible for the failure of anti …

Vasculogenic mimicry (VM), a micro vessel-like structure formed by the cancer cells, plays a
pivotal role in cancer malignancy and progression. Interleukin-1 beta (IL-1β) is an active pro …